European Pharmaceutical Manufacturer Magazine - Equipment and Services to aid Drug Manufacture http://www.epmmagazine.com/downloads/1519/download/bologna.jpg?cb=c351fb6e9ed3dadcc70878a64c1a5031 European Pharmaceutical Manufacturer Magazine is the only product tabloid-style publication in Europe covering the entire manufacturing supply chain and continues to uphold its reputation as a prime and trusted resource for the global industry. en-us © 2014 Rapid Life Sciences Ltd, a Rapid News Communications Group Company. All Rights Reserved. Thu, 24 Jul 2014 14:43:16 GMT Lonza half-year business performance fully on track In the first half of 2014, Lonza’s specialty ingredients and pharma & biotech segments both delivered a sound performance despite currency headwinds and are fully on track to deliver the growth targets.

]]>
http://www.epmmagazine.com/lonza-half-year-business-performance-fully-on-track/ http://www.epmmagazine.com/lonza-half-year-business-performance-fully-on-track/ Thu, 24 Jul 2014 14:43:16 GMT
Xention awarded £1.4m from Technology Strategy Board to develop new medicines for atrial fibrillation The company is now well positioned to advance candidate drugs in its pipeline towards the clinic.

]]>
http://www.epmmagazine.com/xention-awarded-%C2%A31.4m-from-technology-strategy-board-to-deve/ http://www.epmmagazine.com/xention-awarded-%C2%A31.4m-from-technology-strategy-board-to-deve/ Thu, 24 Jul 2014 13:58:42 GMT
Biosimilar Retacrit effective in chemotherapy-induced anemia Results show that the company's European biosimilar epoetin, Retacrit (epoetin zeta) was effective and well tolerated in the management of chemotherapy-induced anemia in patients with solid tumours, lymphoma and myeloma.

]]>
http://www.epmmagazine.com/biosimilar-retacrit-effective-in-chemotherapy-induced-anemia/ http://www.epmmagazine.com/biosimilar-retacrit-effective-in-chemotherapy-induced-anemia/ Thu, 24 Jul 2014 13:36:00 GMT
FDA approves Gilead's Zydelig for three types of blood cancers Zydelig is being granted traditional approval to treat patients whose chronic lymphocytic leukemia (CLL) has returned (relapsed).

]]>
http://www.epmmagazine.com/fda-approves-zydelig-for-three-types-of-blood-cancers/ http://www.epmmagazine.com/fda-approves-zydelig-for-three-types-of-blood-cancers/ Thu, 24 Jul 2014 13:06:00 GMT
Integra pIpette streamlines screening of novel protein therapeutics Integrating an Integra VIAFLO 96 multichannel pipette into their high throughput expression facility has enabled Molecular Partners to streamline the discovery and development of a novel class of targeted protein therapeutics termed DARPins.

]]>
http://www.epmmagazine.com/lab-products/integra-pipette-streamlines-screening-of-novel-protein-thera/ http://www.epmmagazine.com/lab-products/integra-pipette-streamlines-screening-of-novel-protein-thera/ Thu, 24 Jul 2014 12:37:00 GMT
BMS and Ono Pharmaceutical announce strategic immuno-oncology collaboration in Japan, South Korea and Taiwan As part of the agreement, BMS and Ono will jointly develop and commercialise Opdivo (nivolumab) and Yervoy (ipilimumab) across a broad range of tumour types.

]]>
http://www.epmmagazine.com/bms-and-ono-pharmaceutical-announce-strategic-immuno-oncolog/ http://www.epmmagazine.com/bms-and-ono-pharmaceutical-announce-strategic-immuno-oncolog/ Thu, 24 Jul 2014 12:06:57 GMT
Bavarian Nordic announces first patient treated in a phase I study of MVA-BN Brachyury in advanced cancer This immunotherapy is designed to induce a robust immune response against Brachyury, a tumour-associated antigen which is overexpressed in every major solid tumour setting

]]>
http://www.epmmagazine.com/bavarian-nordic-announces-first-patient-treated-in-a-phase-i/ http://www.epmmagazine.com/bavarian-nordic-announces-first-patient-treated-in-a-phase-i/ Thu, 24 Jul 2014 11:51:59 GMT
Roche reports good half year performance Results driven primarily by the company's cancer medicines, particularly the new breast cancer medicines.

]]>
http://www.epmmagazine.com/roche-reports-good-half-year-performance/ http://www.epmmagazine.com/roche-reports-good-half-year-performance/ Thu, 24 Jul 2014 11:15:42 GMT
FDA accepts Sandoz application for biosimilar filgrastim The reference product is indicated to decrease the incidence of infection, as manifested by febrile neutropenia, in patients with nonmyeloid malignancies receiving myelosuppressive anticancer drugs associated with a significant.

]]>
http://www.epmmagazine.com/fda-accepts-sandoz-application-for-biosimilar-filgrastim/ http://www.epmmagazine.com/fda-accepts-sandoz-application-for-biosimilar-filgrastim/ Thu, 24 Jul 2014 11:00:13 GMT
Implandata announces successful implantation of micro-sensor for intraocular pressure measurement in glaucoma patient After implantation of the micro sensor the patient’s intraocular pressure measurements can be measured at any chosen frequency.

]]>
http://www.epmmagazine.com/mplandata-announces-successful-implantation-of-micro-sensor-/ http://www.epmmagazine.com/mplandata-announces-successful-implantation-of-micro-sensor-/ Thu, 24 Jul 2014 10:45:20 GMT
Barrier Pharma Packaging 2014 Global conference on barrier packaging for pharmaceuticals and biologics focusing on markets, technology and materials

]]>
http://www.epmmagazine.com/barrier-pharma-packaging-2014/ http://www.epmmagazine.com/barrier-pharma-packaging-2014/ Wed, 23 Jul 2014 14:19:57 GMT
PhRMA concerned proposed FDA rule could delay excipient import in-Pharma Technologist reports PhRMA's concern that the full implementation of a proposed rule could lead to manufacturing delays.

]]>
http://www.epmmagazine.com/phrma-concerned-proposed-fda-rule-could-delay-excipient-impo/ http://www.epmmagazine.com/phrma-concerned-proposed-fda-rule-could-delay-excipient-impo/ Wed, 23 Jul 2014 14:16:31 GMT
Global hologram trade body targets China growth in new move Initiative to drive awareness and extend reach.

]]>
http://www.epmmagazine.com/phrma-concerned-proposed-fda-will/ http://www.epmmagazine.com/phrma-concerned-proposed-fda-will/ Wed, 23 Jul 2014 12:36:05 GMT
Advancement in liquid dosage excipients (parenteral & transdermal) This study covers in detail the parenteral and transdermal excipients used in the pharmaceutical industry.

]]>
http://www.epmmagazine.com/boston-scientific-launches-polaris-imaging-system/ http://www.epmmagazine.com/boston-scientific-launches-polaris-imaging-system/ Wed, 23 Jul 2014 12:07:56 GMT
Report on experiences with excipient audits At the CPhI China in Shanghai and the ExcipientFest Europe in Amsterdam, the auditors of blue inspection body have now drawn an initial conclusion.

]]>
http://www.epmmagazine.com/--report-on-experiences-with-excipient-audits/ http://www.epmmagazine.com/--report-on-experiences-with-excipient-audits/ Wed, 23 Jul 2014 11:20:32 GMT
BIA and ABPI jointly launch new communication materials to enhance understanding of biosimilar medicines The materials provide an interesting overview on this ever-growing market at a significant time, with biological medicines now amongst today’s most important medicines.

]]>
http://www.epmmagazine.com/bia-and-abpi-jointly-launch-new-communication-materials-to-e/ http://www.epmmagazine.com/bia-and-abpi-jointly-launch-new-communication-materials-to-e/ Wed, 23 Jul 2014 10:57:35 GMT
CPI announces £20m investment into ‘Biologics Factory of the Future’ The new facility will allow organisations to develop and test medicine manufacturing technologies.

]]>
http://www.epmmagazine.com/cpi-announce-%C2%A320m-investment-into-%E2%80%98biologics-factory-of-the-/ http://www.epmmagazine.com/cpi-announce-%C2%A320m-investment-into-%E2%80%98biologics-factory-of-the-/ Wed, 23 Jul 2014 10:19:00 GMT
Onyx to support charity on multiple projects Cancer Research UK is using Onyx Scientific to manage several of its drug development projects in a bid to maximise value for the UK’s leading cancer charity.

]]>
http://www.epmmagazine.com/onyx-to-support/ http://www.epmmagazine.com/onyx-to-support/ Wed, 23 Jul 2014 08:42:00 GMT
Barrier Pharma Packaging Global conference on barrier packaging for pharmaceuticals and biologics focusing on markets, technology and materials

]]>
http://www.epmmagazine.com/events/barrier-pharma-packaging/ http://www.epmmagazine.com/events/barrier-pharma-packaging/ Wed, 23 Jul 2014 08:16:00 GMT
PharmaBoardroom releases new Poland pharmaceutical report The report explores one of Europe's largest pharma markets, and looks at the delicate balance between a strong and growing economy, and healthcare legislation that many complain is negatively affecting the pharmaceutical market.

]]>
http://www.epmmagazine.com/pharmaboardroom-releases-new-poland-pharmaceutical-report/ http://www.epmmagazine.com/pharmaboardroom-releases-new-poland-pharmaceutical-report/ Thu, 17 Jul 2014 14:26:18 GMT
Xellia Pharmaceuticals expands into the US with acquisition of manufacturing plant The manufacturing site significantly expanding the company’s manufacturing capacity for injectable pharmaceutical products.

]]>
http://www.epmmagazine.com/xellia-pharmaceuticals-expands-into-the-us-with-acquisition-/ http://www.epmmagazine.com/xellia-pharmaceuticals-expands-into-the-us-with-acquisition-/ Thu, 17 Jul 2014 13:58:02 GMT
West dedicates pharmaceutical manufacturing plant in India The company has dedicated its manufacturing plant in the Sri City Special Economic Zone, where the company will expand its growing primary packaging for injectable medicines business.

]]>
http://www.epmmagazine.com/west-dedicates-pharmaceutical-manufacturing-plant-in-india/ http://www.epmmagazine.com/west-dedicates-pharmaceutical-manufacturing-plant-in-india/ Thu, 17 Jul 2014 13:10:00 GMT
Pfizer to acquire InnoPharma InnoPharma’s current portfolio includes 10 generic products approved by FDA. The company also has a pipeline of 19 products filed with FDA and more than 30 injectable and ophthalmic products under development.

]]>
http://www.epmmagazine.com/pfizer-to-acquire-innopharma/ http://www.epmmagazine.com/pfizer-to-acquire-innopharma/ Thu, 17 Jul 2014 12:48:02 GMT
Glenmark Pharmaceuticals to set up a new manufacturing facility in the US The facility will be spread over 100,000 sq. ft (around 15 acre plot) and the company will first begin work on an oral solid unit and thereafter set up manufacturing units for injectables and topicals.

]]>
http://www.epmmagazine.com/glenmark-pharmaceuticals-to-set-up-a-new-manufacturing-facil/ http://www.epmmagazine.com/glenmark-pharmaceuticals-to-set-up-a-new-manufacturing-facil/ Thu, 17 Jul 2014 12:31:54 GMT
Codexis announces technology collaboration and licence agreement with GSK The licence allows GSK to use Codexis' platform technology to develop novel enzymes for use in the manufacture of GSK's pharmaceutical and healthcare products.

]]>
http://www.epmmagazine.com/codexis-announces-technology-collaboration-and-licence-agree/ http://www.epmmagazine.com/codexis-announces-technology-collaboration-and-licence-agree/ Thu, 17 Jul 2014 12:03:53 GMT
New method may lessen breast cancer drug’s side effects A drug that has proven effective in the prevention and treatment of breast cancer, but with serious side-effects, may be delivered effectively through the skin using a new topical drug-delivery system.

]]>
http://www.epmmagazine.com/new-method-may-lessen-breast-cancer-drug%E2%80%99s-side-effects/ http://www.epmmagazine.com/new-method-may-lessen-breast-cancer-drug%E2%80%99s-side-effects/ Thu, 17 Jul 2014 11:50:00 GMT
High vacuum benchtop solvent evaporator Genevac's EZ-2 Elite centrifugal evaporator has been designed to provide unmatched final drying of stubborn samples and fast lyophilisation of HPLC fractions.

]]>
http://www.epmmagazine.com/lab-products/high-vacuum-benchtop-solvent-evaporator/ http://www.epmmagazine.com/lab-products/high-vacuum-benchtop-solvent-evaporator/ Thu, 17 Jul 2014 11:33:00 GMT
Study shows beta-amyloid imaging is associated with altered diagnosis and management of Alzheimer's disease Change in management was observed in both patients who met and did not meet the appropriate use criteria.

]]>
http://www.epmmagazine.com/v/ http://www.epmmagazine.com/v/ Thu, 17 Jul 2014 11:22:39 GMT
Aesica Zwickau marks 20th anniversary with continued growth and expansion of its encapsulation services business The facility possesses multiple solid oral dosage form technologies and service capabilities and has been integral in fast establishing Aesica as a leading provider of encapsulation services.

]]>
http://www.epmmagazine.com/aesica-zwickau-marks-20th-anniversary-with-continued-growth-/ http://www.epmmagazine.com/aesica-zwickau-marks-20th-anniversary-with-continued-growth-/ Wed, 16 Jul 2014 12:22:23 GMT
Thermo Fisher Scientific transforms chromatography by reimagining UHPLC Thermo has unveiled a new high performance liquid chromatography system designed from the ground up to provide new levels of performance, productivity and usability when used as a standalone system or with the latest mass spectrometers.

]]>
http://www.epmmagazine.com/lab-products/thermo-fisher-scientific-transforms-chromatography-by-reimag/ http://www.epmmagazine.com/lab-products/thermo-fisher-scientific-transforms-chromatography-by-reimag/ Wed, 16 Jul 2014 12:08:00 GMT
Valeant Pharmaceuticals completes sale of filler and toxin assets to Galderma Valeant Pharmaceuticals International has completed the sale to Galderma of all rights to Restylane, Perlane, Emervel, Sculptra, and Dysport owned or held by Valeant for $1.4 billion in cash, pursuant to the previously announced agreement with Nestle

]]>
http://www.epmmagazine.com/valeant-pharmaceuticals-completes-sale-of-filler-and-toxin-a/ http://www.epmmagazine.com/valeant-pharmaceuticals-completes-sale-of-filler-and-toxin-a/ Wed, 16 Jul 2014 10:56:47 GMT
Protective EPS packaging is successfully moulding the pharmaceutical supply chain Expanded polystyrene (EPS) is the safest, most cost-effective and environmentally friendly packaging for transporting drugs and medicines, according to a global company targeting the UK pharmaceutical industry.

]]>
http://www.epmmagazine.com/manufacturing-products/protective-eps-packaging-is-successfully-moulding-the-pharma/ http://www.epmmagazine.com/manufacturing-products/protective-eps-packaging-is-successfully-moulding-the-pharma/ Wed, 16 Jul 2014 10:38:27 GMT
The Open Medicine Institute launches novel bioinformatics-healthcare research platform This integrated healthcare model represents a new approach that many experts believe will improve the outlook for patients.

]]>
http://www.epmmagazine.com/the-open-medicine-institute-launches-novel-bioinformatics-he/ http://www.epmmagazine.com/the-open-medicine-institute-launches-novel-bioinformatics-he/ Wed, 16 Jul 2014 10:12:05 GMT
Celanese presents predictive modeling from EVA Polymers at Controlled Release Society's 41st annual meeting & expo Celanese presents a poster session entitled “Predictive Modeling and Validation of Tamoxifen Release from EVA Copolymers.”

]]>
http://www.epmmagazine.com/celanese-presents-predictive-modeling-from-eva-polymers-at-c/ http://www.epmmagazine.com/celanese-presents-predictive-modeling-from-eva-polymers-at-c/ Wed, 16 Jul 2014 09:54:00 GMT
Cardinal Health supports future pharmacists with $2 million in scholarships Company has donated nearly $4.2 million to more than 20 universities through its nationwide pharmacy scholarship program, now in its fourth year

]]>
http://www.epmmagazine.com/cardinal-health-supports-future-pharmacists-with-%242-million-/ http://www.epmmagazine.com/cardinal-health-supports-future-pharmacists-with-%242-million-/ Thu, 10 Jul 2014 14:32:04 GMT
Reaction Biology receives NIH grant award For epigenetic database The grant will help fund an examination of the interaction of over 1400 FDA-approved drugs and drug-like compounds with over 30 epigenetic modifying enzymes.

]]>
http://www.epmmagazine.com/reaction-biology-receives-nih-grant-award-for-epigenetic-dat/ http://www.epmmagazine.com/reaction-biology-receives-nih-grant-award-for-epigenetic-dat/ Thu, 10 Jul 2014 14:19:04 GMT
Personalised cellular therapy for leukemia receives breakthrough therapy designation CTL019, is the first personalised cellular therapy for the treatment of cancer to receive this important classification.

]]>
http://www.epmmagazine.com/university-of-pennsylvania%27s-personalised-cellular-therapy-f/ http://www.epmmagazine.com/university-of-pennsylvania%27s-personalised-cellular-therapy-f/ Thu, 10 Jul 2014 14:05:00 GMT
Novartis reinforces its leadership in research with new global guidelines for investigator initiated trials Clinical research undertaken through IITs must be based on the need to address meaningful scientific and/or clinical objectives supported by valid scientific designs while respecting the privacy rights, safety and welfare of patients.

]]>
http://www.epmmagazine.com/novartis-reinforces-its-leadership-in-research-with-new-glob/ http://www.epmmagazine.com/novartis-reinforces-its-leadership-in-research-with-new-glob/ Thu, 10 Jul 2014 13:49:21 GMT
Beatson Clark's new machine caps it all The equipment will allow Beatson Clark to fulfil a contract with a major high street chemist to supply pre-capped alpha sirops, continental winchesters and bespoke round bottles.

]]>
http://www.epmmagazine.com/manufacturing-products/beatson-clark%27s-new-machine-caps-it-all/ http://www.epmmagazine.com/manufacturing-products/beatson-clark%27s-new-machine-caps-it-all/ Thu, 10 Jul 2014 13:34:52 GMT
Concept Life Sciences creates a UK based $100 million life sciences group with more acquisitions planned The companies the group has acquired are Peakdale Molecular, Resource & Environmental Consultants and Scientific Analysis Laboratories.

]]>
http://www.epmmagazine.com/valeant-pharmaceuticals-completes-acquisition-of-precision-d/ http://www.epmmagazine.com/valeant-pharmaceuticals-completes-acquisition-of-precision-d/ Thu, 10 Jul 2014 13:16:00 GMT
Aesica concentrates investment in lucrative German formulations business Zwickau site introduces roller compaction unit for dry granulation production

]]>
http://www.epmmagazine.com/aesica-concentrates-investment-in-lucrative-german-formulati/ http://www.epmmagazine.com/aesica-concentrates-investment-in-lucrative-german-formulati/ Thu, 10 Jul 2014 12:50:34 GMT
FDA accepts Sanofi's NDA for basal insulin Toujeo The acceptance of the NDA follows the acceptance of the marketing authorization dossier for Toujeo by the European Medicines Agency (EMA) for EU countries on 27 May 2014.

]]>
http://www.epmmagazine.com/fda-accepts-sanofi%27s-new-drug-application-for-basal-insulin-/ http://www.epmmagazine.com/fda-accepts-sanofi%27s-new-drug-application-for-basal-insulin-/ Thu, 10 Jul 2014 12:44:00 GMT
Domainex reports success of its lead compound in pre-clinical model of COPD and secures £1.4 million Biomedical Catalyst Award The Domainex compound showed more than twice the effect of the comparator drugs in reducing the cigarette smoke-induced influx of inflammatory cells, particularly neutrophils, into the lung.

]]>
http://www.epmmagazine.com/domainex-reports-success-of-its-lead-compound-in-pre-clinica/ http://www.epmmagazine.com/domainex-reports-success-of-its-lead-compound-in-pre-clinica/ Thu, 10 Jul 2014 12:24:00 GMT
Access Pharmaceuticals awarded Hong Kong Patent For MuGard Company continues reinforcing intellectual property protection in additional global markets

]]>
http://www.epmmagazine.com/access-pharmaceuticals-awarded-hong-kong-patent-for-mugard/ http://www.epmmagazine.com/access-pharmaceuticals-awarded-hong-kong-patent-for-mugard/ Thu, 10 Jul 2014 12:18:00 GMT
Ario Pharma commences efficacy trial of TRPV1 inhibitor in chronic idiopathic cough XEN-D0501, a potent and selective small molecule inhibitor of TRPV1, has successfully completed multiple Phase I studies and been shown to be safe and well tolerated.

]]>
http://www.epmmagazine.com/ario-pharma-commences-efficacy-trial-of-trpv1-inhibitor-in-c/ http://www.epmmagazine.com/ario-pharma-commences-efficacy-trial-of-trpv1-inhibitor-in-c/ Thu, 10 Jul 2014 12:07:00 GMT
Mitsubishi Electric Europe and Robotronic presents world’s first syringe handling solution with a small footprint The unique concept takes up very little space, yet offers a high processing rate of up to 600 syringes per minute and the option of switching quickly and easily between various syringe and carrier formats.

]]>
http://www.epmmagazine.com/manufacturing-products/mitsubishi-electric-europe-and-robotronic-presents-world%E2%80%99s-f/ http://www.epmmagazine.com/manufacturing-products/mitsubishi-electric-europe-and-robotronic-presents-world%E2%80%99s-f/ Thu, 10 Jul 2014 11:49:00 GMT
Therapy for anal fistulas, FiLaC, allows for maximum chances of recovery within the shortest of time Removal of fistula tract feasible without harming the sphincter — fast recovery and convincing results

]]>
http://www.epmmagazine.com/industry/one-of-a-kind%3A-therapy-for-anal-fistulas%2C-filac%C2%AE%2C-allows-for/ http://www.epmmagazine.com/industry/one-of-a-kind%3A-therapy-for-anal-fistulas%2C-filac%C2%AE%2C-allows-for/ Thu, 10 Jul 2014 11:24:00 GMT
Review of ADHD drug approvals highlights gaps Over the last 60 years, FDA approved 20 medications for ADHD based on clinical trials that were not designed to study their long-term efficacy and safety or to detect rare adverse events,

]]>
http://www.epmmagazine.com/review-of-adhd-drug-approvals-highlights-gaps-between-pediat/ http://www.epmmagazine.com/review-of-adhd-drug-approvals-highlights-gaps-between-pediat/ Thu, 10 Jul 2014 10:14:00 GMT
Proveca gains fourth key agreement with EMA The EMA’s Paediatric Committee (PDCO) adopted a positive opinion on the paediatric investigation plan (PIP) for the development of captopril — a drug designed to treat heart failure in children.

]]>
http://www.epmmagazine.com/proveca-gains-fourth-key-agreement-with-ema/ http://www.epmmagazine.com/proveca-gains-fourth-key-agreement-with-ema/ Thu, 10 Jul 2014 09:59:53 GMT
BolognaFiere acquires Pharmintech BolognaFiere and Ipack-Ima have reached an agreement to transfer the shares of Pharmintech (organizer of Pharmintech) to BolognaFiere.

]]>
http://www.epmmagazine.com/bolognafiere-acquires-pharmintech/ http://www.epmmagazine.com/bolognafiere-acquires-pharmintech/ Thu, 10 Jul 2014 09:49:22 GMT